Skip to main content
. Author manuscript; available in PMC: 2022 Sep 2.
Published in final edited form as: Nat Rev Neurosci. 2021 Oct 18;22(12):758–776. doi: 10.1038/s41583-021-00526-9

Table 1 |.

Approaches used to define itch-specific neuropeptides and neurons

Manipulation Criteria Advantages Disadvantages
Assessment of behavioural correlates of itch
Loss of neuropeptide function in mice (via genetic KO or siRNA-mediated knockdown) Impaired itch behaviour and normal pain behaviour Direct evidence
Sensory neuron-specific KO is feasible
Compensation: multiple related neuropeptides and receptors
Time consuming to generate double-KO or triple-KO mice and CKO mice
Spinally restricted CKO may not be feasible
Chemogenetic or optogenetic inhibition or viral, chemical or intersectional genetic ablation of neurons Impaired itch behaviour and normal pain behaviour Spinally restricted inhibition/ablation possible
Sensory neuron-specific inhibition/ablation possible
Ablation can be fast and efficient
Low level of fidelity of a Cre line
Neurotoxin approach may have off-target effects
Most acute pain behaviour cannot be appropriately evaluated after cervical inhibition or ablation
Genetic compensation
Indirect effects
Loss of neuropeptide function via pharmacological approaches Impaired itch behaviour and normal pain behaviour Acute and convenient
Agonists may be available
Dose-dependent scratching behaviour can be assessed
Off-target effects
Potential presynaptic effects originating in primary afferents
Pharmacological artefacts
Gain of neuropeptide function via pharmacological approaches Induced itch behaviour and normal pain behaviour Acute and convenient
Agonists may be available
Dose-dependent scratching behaviour can be assessed
Off-target effects
Potential presynaptic effects originating in primary afferents
Pharmacological artefacts
Ceiling or floor effects
Chemogenetic or optogenetic activation of neurons Induced itch behaviour and normal pain behaviour Spinal cervical cord-restricted activation
Validation using BB-sap possible
Sensory neuron-specific activation of central or peripheral fibres possible
Low level of fidelity of a Cre line
Chemogenetic or optogenetic artefacts
Artificial behaviour can only suggest the capacity of fibres and is not necessarily an indicator of an endogenous function of manipulated neurons
Assessment of neural correlates of itch
Electrophysiological recording of neuronal responses to chemical itch, pain, cooling or scratching Inhibited by pain stimuli Single-cell resolution
Cell-type recording
Low level of fidelity of Cre or eGFP mouse lines
Lack of specificity of some chemicals (e.g. capsaicin)
May not simulate neuropeptide release in freely behaving animals

BB-sap, bombesin–saporin; CKO, conditional knockout; eGFP, enhanced GFP; KO, knockout; siRNA, small interfering RNA.